01 · PRODUCT INFORMATION
About KPV 10mg (Lys-Pro-Val)
KPV 10mg is a synthetic tripeptide research material supplied as a lyophilised solid. The name KPV represents its three-amino-acid sequence: lysine, proline and valine.
KPV corresponds to the C-terminal amino-acid sequence of alpha-melanocyte-stimulating hormone, commonly abbreviated as α-MSH. It is investigated in laboratory models involving epithelial transport, cellular signalling, inflammatory-response pathways and peptide–cell interactions.
KPV Research Overview
KPV is a short tripeptide represented by the sequence Lys–Pro–Val. It corresponds to amino-acid residues 11–13 of α-MSH but must be treated as a distinct research material rather than as full-length α-MSH.
Its short structure has made KPV relevant to research involving peptide transport, cellular uptake, biological stability and sequence-specific activity.
Published findings involving KPV remain based largely on isolated cells, tissues and preclinical models. They do not establish a medical, gastrointestinal, dermatological or therapeutic benefit in humans.
Epithelial Transport and Cellular-Signalling Research
Laboratory studies have examined KPV uptake through the peptide transporter PepT1 and its behaviour within experimental epithelial and intestinal models.
Other research has explored KPV in relation to NF-κB-associated signalling, cytokine responses and microbial growth under controlled experimental conditions. These areas describe research targets and do not represent proven outcomes for the supplied product.
Findings involving α-MSH or modified KPV sequences should not automatically be attributed to unmodified KPV without appropriate analytical and experimental validation.
Product Specifications
-
Product name: KPV
-
Expanded sequence: Lysine–Proline–Valine
-
Peptide length: Three amino acids
-
Unit strength: 10mg
-
Unit quantity: One vial
-
Form: Lyophilised solid
-
Product class: Synthetic tripeptide research material
-
Intended use: Laboratory and analytical research only
Storage and Handling
KPV is supplied as a sealed lyophilised solid. Unless the batch documentation specifies otherwise, store the sealed vial at -20°C, protected from direct light, heat and moisture. Avoid unnecessary temperature cycling.
All storage decisions, material preparation and experimental procedures remain the responsibility of the receiving laboratory and must follow its validated protocols.
For further information, visit the Helix Bio Peptide Storage and Stability Guide.
Quality Assurance and Batch Documentation
Researchers should consult the corresponding batch documentation and analytical report when evaluating the sequence, identity, composition and purity of KPV 10mg.
Laboratory documentation is being added as independent reports are returned and reviewed. Visit our Certificates of Analysis page to view available reports and current testing status.
Research Use and Safety Information
Helix Bio supplies KPV 10mg strictly for scientific, laboratory and analytical research.
This product is not a medicine and is not intended for human consumption, veterinary use, clinical application, diagnosis, treatment or prevention of any medical condition. Helix Bio does not provide medical advice, dosage guidance, administration instructions or therapeutic recommendations.
Important: Helix Bio products are sold strictly for research purposes only. Enquiries concerning personal use or human consumption are prohibited.
Important: Product information is provided for laboratory and analytical research. It does not provide dosing, administration, treatment or human-use guidance.
